0.5700
-0.0100
(-1.72%)
At close: January 10 at 2:08:32 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
2/28/2022
12/31/2021
Operating Cash Flow
-4,078.6060
-3,248.4630
-2,089.6930
-67.0760
-768.1300
Investing Cash Flow
--
--
107.4570
--
--
Financing Cash Flow
4,590.7260
4,121.2260
8,126.6310
3,326.7580
818.5150
End Cash Position
4,143.7360
7,076.3080
6,195.9610
3,406.1130
62.5490
Issuance of Capital Stock
--
4,121.2260
4,879.9700
--
674.8130
Issuance of Debt
--
--
--
--
143.7020
Repayment of Debt
--
--
-175.1720
--
--
Free Cash Flow
-4,078.6060
-3,248.4630
-2,089.6930
-67.0760
-768.1300
12/31/2021 - 4/13/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NWRN.SW Newron Pharmaceuticals S.p.A.
8.88
+1.72%
SANN.SW Santhera Pharmaceuticals Holding AG
13.68
-2.84%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
RKV.V Rakovina Therapeutics Inc.
0.1750
-2.78%
IDIA.SW Idorsia Ltd
0.7790
-1.77%
GBIO Generation Bio Co.
0.9255
+1.69%
BOLT Bolt Biotherapeutics, Inc.
0.5387
-4.69%
SVA.TO Sernova Corp.
0.2250
0.00%
NCNA NuCana plc
1.1300
-1.74%
PBM Psyence Biomedical Ltd.
1.7000
-7.61%